GlassScriptPhysician profile
Maged M George
NPI 1326029331
$5,365.93
in general payments reported to CMS, 2019-2025
19 companies · $281 in 2025
The $281 reported for 2025 was more than what 83% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,314 · 2020: $173 · 2021: $541 · 2022: $227 · 2023: $457 · 2024: $373 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $3,386.44 | 2019-2023 | Qelbree |
| Ironshore Pharmaceuticals INC. | $628.66 | 2019-2024 | Jornay Pm |
| Corium, LLC | $211.92 | 2022-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $166.35 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $161.33 | 2025 | Jornay Pm |
| Gm Pharmaceuticals, INC. | $145.27 | 2023 | Vanacof |
| Glaxosmithkline, LLC. | $128.95 | 2019-2022 | |
| Teleflex LLC | $125.00 | 2024 | Urolift |
| Axsome Therapeutics, INC. | $124.99 | 2024 | Auvelity |
| Tris Pharma INC | $44.35 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $35.76 | 2024-2025 | |
| Vertical Pharmaceuticals, LLC | $34.96 | 2025 | Relexxii |
| Cranial Technologies, INC | $32.66 | 2021-2023 | Doc Band |
| Acadia Pharmaceuticals INC | $32.48 | 2025 | Daybue |
| Merck Sharp & Dohme LLC | $27.95 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cipher Pharmaceuticals US LLC | $25.13 | 2025 | Natroba, Spinosad |
| Sanofi Pasteur INC. | $21.00 | 2022 | |
| Alexion Pharmaceuticals, INC. | $16.96 | 2021 | |
| Rhodes Pharmaceuticals L.P. | $15.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maged George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.